These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32449625)

  • 1. "My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life.
    Perry KE; Dubé K; Concha-Garcia S; Patel H; Kaytes A; Taylor J; Javadi SS; Mathur K; Lo M; Brown B; Sauceda JA; Wohl DA; Little S; Hendrickx S; Rawlings SA; Smith DM; Gianella S
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1071-1082. PubMed ID: 32449625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "[It] is now my responsibility to fulfill that wish:" Clinical and rapid autopsy staff members' experiences and perceptions of HIV reservoir research at the end of life.
    Perry KE; Taylor J; Patel H; Javadi SS; Mathur K; Kaytes A; Concha-Garcia S; Little S; Smith D; Gianella S; Dubé K
    PLoS One; 2020; 15(11):e0242420. PubMed ID: 33206710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Next-of-Kin/Loved Ones About Last Gift Rapid Research Autopsy Study Enrolling People with HIV/AIDS at the End of Life: A Qualitative Interview Study.
    Dubé K; Patel H; Concha-Garcia S; Perry KE; Mathur K; Javadi SS; Taylor J; Kaytes A; Brown B; Sauceda JA; Little S; Hendrickx S; Rawlings SA; Smith DM; Gianella S
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1033-1046. PubMed ID: 32449624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical considerations for HIV cure-related research at the end of life.
    Dubé K; Gianella S; Concha-Garcia S; Little SJ; Kaytes A; Taylor J; Mathur K; Javadi S; Nathan A; Patel H; Luter S; Philpott-Jones S; Brown B; Smith D
    BMC Med Ethics; 2018 Oct; 19(1):83. PubMed ID: 30342507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United States.
    Dubé K; Shelton B; Patel H; Ndukwe SO; Concha-Garcia S; Dullano C; Solso S; Hendrickx S; Kaytes A; Taylor J; Villa TJ; Little SJ; Riggs PK; Lessard D; Arora AK; Costiniuk CT; Eskaf S; Smith DM; Gianella S
    J Virus Erad; 2023 Jun; 9(2):100328. PubMed ID: 37440872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from the Last Gift study: ethical and practical challenges faced while conducting HIV cure-related research at the end of life.
    Kanazawa J; Rawlings SA; Hendrickx S; Gianella S; Concha-Garcia S; Taylor J; Kaytes A; Patel H; Ndukwe S; Little SJ; Smith D; Dubé K
    J Med Ethics; 2023 May; 49(5):305-310. PubMed ID: 35732421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States.
    Kanazawa J; Gianella S; Concha-Garcia S; Taylor J; Kaytes A; Christensen C; Patel H; Ndukwe S; Rawlings SA; Hendrickx S; Little S; Brown B; Smith D; Dubé K
    BMC Med Ethics; 2022 Jan; 23(1):2. PubMed ID: 35012544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research.
    Ndukwe SO; Patel H; Shelton B; Concha-Garcia S; Dullano C; Solso S; Hendrickx S; Riggs PK; Villa TJ; Kaytes A; Taylor J; Little SJ; Lessard D; Arora AK; Costiniuk CT; Eskaf S; Smith DM; Gianella S; Dubé K
    AIDS; 2024 Feb; 38(2):235-243. PubMed ID: 37861674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes and perceptions of next-of-kin/loved ones toward end-of-life HIV cure-related research: A qualitative focus group study in Southern California.
    Javadi SS; Mathur K; Concha-Garcia S; Patel H; Perry KE; Lo M; Taylor J; Kaytes A; Little S; Gianella S; Smith D; Dubé K
    PLoS One; 2021; 16(5):e0250882. PubMed ID: 33961653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States.
    Kanazawa J; Gianella S; Concha-Garcia S; Taylor J; Kaytes A; Christensen C; Patel H; Ndukwe S; Rawlings S; Hendrickx S; Little S; Brown B; Smith D; Dubé K
    PLoS One; 2021; 16(7):e0254148. PubMed ID: 34270612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method Study.
    Lessard D; Dubé K; Bilodeau M; Keeler P; Margolese S; Rosenes R; Sinyavskaya L; Durand M; Benko E; Kovacs C; Guerlotté C; Tharao W; Arnold K; Masching R; Taylor D; Sousa J; Ostrowski M; Taylor J; Kaytes A; Smith D; Gianella S; Chomont N; Angel JB; Routy JP; Cohen ÉA; Lebouché B; Costiniuk CT
    AIDS Res Hum Retroviruses; 2022 Aug; 38(8):670-682. PubMed ID: 35778845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.
    Dubé K; Taylor J; Sylla L; Evans D; Dee L; Burton A; Willenberg L; Rennie S; Skinner A; Tucker JD; Weiner BJ; Greene SB
    PLoS One; 2017; 12(1):e0170112. PubMed ID: 28122027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donating One's Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case Study.
    Lessard D; Lebouché B; Morneau A; Bilodeau M; Rosenes R; Sanders J; Chomont N; Keeler P; Dubé K; Margolese S; Jenabian MA; Power C; Routy JP; Angel JB; Cohen ÉA; Costiniuk CT
    Curr HIV Res; 2023; 21(4):264-267. PubMed ID: 37670698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.
    Riggs PK; Chaillon A; Jiang G; Letendre SL; Tang Y; Taylor J; Kaytes A; Smith DM; Dubé K; Gianella S
    Curr HIV/AIDS Rep; 2022 Dec; 19(6):566-579. PubMed ID: 36260191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Community-Driven Framework to Prioritize the Use of Donated Human Biological Materials in the Context of HIV Cure-Related Research at the End of Life.
    Dubé K; Villa TJ; Taylor J; Kaytes A; Moore DJ; Little SJ; Chaillon A; Smith DM; Gianella S
    Pathog Immun; 2023; 8(1):1-16. PubMed ID: 37252012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.
    Dubé K; Kanazawa J; Patel H; Louella M; Sylla L; Sheehy J; Dee L; Taylor J; Adair J; Anthony-Gonda K; Dropulić B; Sauceda JA; Peluso MJ; Deeks SG; Simoni J
    BMC Med Ethics; 2022 Apr; 23(1):39. PubMed ID: 35397551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study.
    Sylla L; Evans D; Taylor J; Gilbertson A; Palm D; Auerbach JD; Dubé K
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):56-66. PubMed ID: 29198134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
    Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.
    Dubé K; Ndukwe SO; Korolkova A; Dee L; Sugarman J; Sauceda JA
    HIV Res Clin Pract; 2024 Jan; 25(1):2312318. PubMed ID: 38348830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.